Drug Shortage Report for TEVA-CARBAMAZEPINE

Last updated on 2019-05-28 History
Report ID 983
Drug Identification Number 00782718
Brand name TEVA-CARBAMAZEPINE
Common or Proper name Carbamazepine
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-11-01
Estimated end date 2019-05-30
Actual end date 2019-05-15
Shortage status Resolved
Updated date 2019-05-28
Company comments Releases throughout 2018 but have not been able to support all additional demand.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-05-28 French Compare
v9 2019-05-28 English Compare
v8 2019-04-25 French Compare
v7 2019-04-25 English Compare
v6 2019-04-25 English Compare
v5 2019-04-25 French Compare
v4 2019-04-25 English Compare
v3 2017-03-14 French Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare